Switch to:
More From Other Websites
GlaxoSmithKline's Sideways Dance May Pay Off in the Long Run Jul 22 2016
GlaxoSmithKline Segments That Drive Company’s Rising Revenues Jul 22 2016
GSK’s HIV Products Expected to Have Driven 2Q Earnings Jul 22 2016
BioFlash podcast: Why Big Pharma is hungry for bacteria Jul 22 2016
[$$] Front-running: a fuzzy area baked into the way markets work Jul 22 2016
VBIV: A Differentiated Immunology Company With Multiple Near Term Value Drivers Jul 20 2016
Your inhaler's watching you: drugmakers race for smart devices Jul 20 2016
Your inhaler's watching you: drugmakers race for smart devices Jul 20 2016
Your inhaler's watching you: drugmakers race for smart devices Jul 20 2016
Where GSK ranks in R&D spending against sales and marketing Jul 19 2016
Novartis in no rush to sell down stake on GSK consumer venture Jul 19 2016
Novartis in no rush to sell down stake on GSK consumer venture Jul 19 2016
Will GlaxoSmithKline plc and AstraZeneca plc continue to be Brexit winners? Jul 19 2016
The iPhone is being used to study rheumatoid arthritis Jul 18 2016
Why GlaxoSmithKline, Groupon, Lending Club And 2 Micro-Caps Are Trending Today Jul 18 2016
4 High Dividend Yields Close to 5% That Are Often Overlooked Jul 18 2016
These 5 FTSE 100 stars are looking far too cheap! Jul 18 2016
Glaxo Gains Jefferies Upgrade on Stronger HIV Drugs Performance, Currency Benefits Jul 14 2016
BUZZ-GSK dividend looks safe post-Brexit, even with new CEO Jul 14 2016
Grab this 5% yield while you still can! Jul 14 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK